A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database

Clinical trial NCT05236257 · COMPLETED

Trial details

NCT number: NCT05236257
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion Infantile Fibrosarcoma

Start date: 2022-03-10
Primary completion: 2022-09-13
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.